U.S. Markets close in 5 hrs 40 mins

EnteroMedics Inc. (ETRM)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.8784-0.10 (-2.04%)
As of 10:16AM EDT. Market open.
People also watch
IDXGPULMBIOCXGTIGLBS
Full screen
Previous Close4.9800
Open4.9400
Bid4.8900 x 200
Ask4.9400 x 200
Day's Range4.8401 - 4.9400
52 Week Range0.0400 - 30.4100
Volume26,464
Avg. Volume568,415
Market Cap33.69M
Beta2.59
PE Ratio (TTM)-0.43
EPS (TTM)-11.42
Earnings DateMay 4, 2017 - May 8, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.00
Trade prices are not sourced from all markets
  • EnteroMedics Added to Russell Microcap® Index
    PR Newswire3 hours ago

    EnteroMedics Added to Russell Microcap® Index

    ST. PAUL, Minn., June 26, 2017 /PRNewswire/ -- EnteroMedics Inc. (ETRM), the developer of medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the Company will join the Russell Microcap® Index effective after the U.S. market opens today. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. "EnteroMedics is very pleased to be added to such a widely referenced index," said Dan Gladney, EnteroMedics President, Chief Executive Officer and Chairman of the Board.

  • EnteroMedics Announces vBloc Therapy to be Presented by Keynote Speaker at Major International Obesity Conference
    PR Newswire5 days ago

    EnteroMedics Announces vBloc Therapy to be Presented by Keynote Speaker at Major International Obesity Conference

    ST. PAUL, Minn., June 21, 2017 /PRNewswire/ -- EnteroMedics Inc. (ETRM), the developer of medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Scott Shikora, M.D, F.A.C.S., F.A.S.M.B.S., the Company's Consulting Medical Director, Professor of Surgery at Harvard Medical School and Director of the Center for Metabolic and Bariatric Surgery at Brigham and Women's Hospital in Boston, will present information about the Company's vBloc® Neurometabolic Therapy as part of a presentation on neuromodulation for the treatment of obesity. The presentation will take place at the upcoming XIX International Congress of Surgery for Obesity and Metabolic Diseases, June 28-July 1, Playa del Carmen, Mexico.

  • Thomson Reuters StreetEvents19 days ago

    Edited Transcript of ETRM earnings conference call or presentation 7-Mar-17 4:00pm GMT

    Q4 2016 EnteroMedics Inc Earnings Call